NCT02244580View on ClinicalTrials.gov

"Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit MammaTyperTM"

NACompletedINTERVENTIONAL
Enrollment

1,010

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Invasive Breast Cancer
Interventions
DEVICE

MammaTyper™

MammaTyper™ kit is a molecular in vitro diagnostic test for the quantitative detection of the ribonuclease acid (RNA) expression status of the genes for estrogen receptor (ESR1), progesterone receptor (PGR), human epidermal growth factor receptor 2 (HER2) and proliferation antigen KI 67.

Sponsors
All Listed Sponsors
lead

BioNTech Diagnostics GmbH

INDUSTRY